BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang JL, Ding HR, Pan CY, Shi XL, Ren HZ. Mesenchymal stem cells ameliorate lipid metabolism through reducing mitochondrial damage of hepatocytes in the treatment of post-hepatectomy liver failure. Cell Death Dis 2021;12:111. [PMID: 33479191 DOI: 10.1038/s41419-020-03374-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sparrelid E, Olthof PB, Dasari BVM, Erdmann JI, Santol J, Starlinger P, Gilg S. Current evidence on posthepatectomy liver failure: comprehensive review. BJS Open 2022;6:zrac142. [PMID: 36415029 DOI: 10.1093/bjsopen/zrac142] [Reference Citation Analysis]
2 S S, Dahal S, Bastola S, Dayal S, Yau J, Ramamurthi A. Stem Cell Based Approaches to Modulate the Matrix Milieu in Vascular Disorders. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.879977] [Reference Citation Analysis]
3 Shokravi S, Borisov V, Zaman BA, Niazvand F, Hazrati R, Khah MM, Thangavelu L, Marzban S, Sohrabi A, Zamani A. Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review. Stem Cell Res Ther 2022;13:192. [PMID: 35527304 DOI: 10.1186/s13287-022-02825-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Wang J, Huang D, Yu H, Cheng Y, Ren H, Zhao Y. Developing tissue engineering strategies for liver regeneration. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.02.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
5 Huang D, Zhang X, Fu X, Zu Y, Sun W, Zhao Y. Liver spheroids on chips as emerging platforms for drug screening. Engineered Regeneration 2021;2:246-56. [DOI: 10.1016/j.engreg.2021.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]